Aethlon Medical Inc (AEMD)

[Murph1953]

Exthera -

August 30, 2017

U.S. Food and Drug Administration (FDA) has granted ExThera’s Seraph® 100 Blood Filter (Seraph) the agency’s Expedited Access Pathway (EAP)

"..INITIAL INDICATION for use will be ‘as an adjunctive treatment for bacteremia in addition to antibiotics for
patients receiving hemodialysis when the source of the infection is a heparin- or heparan sulfate-binding bacteria,
including antibiotic resistant bacteria MRSA, VRE, ESBL, CRE, and MRSE.’

"..a growing body of data from independent laboratory studies, including testing within DARPA’s Dialysis-Like Therapeutics program.

http://www.extheramedical.com/news-releases/2017/8/30/fda-grants-exthera-medicals-seraph-100-blood-filter-expedited-access-pathway-eap-designation
*************************
On their website they claim efficacy re viruses and cytukines

"..designed to capture and remove a broad range of bacteria, viruses (AEMD), toxins and sepsis-causing pro-inflammatory cytokines(CTSO) from whole blood.

http://www.extheramedical.com/
********************************

MeMed

"...distinguishes between bacterial and viral infections..ImmunoXpert™ provides physicians with rapid and actionable clinical information to help guide..

http://www.me-med.com/